Shenzhen Weiguang Biological Products Co (SZSE:002880) Net Income From Continuing Operations : ¥219 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Shenzhen Weiguang Biological Products Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥47 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥219 Mil.

Shenzhen Weiguang Biological Products Co Net Income From Continuing Operations Historical Data

The historical data trend for Shenzhen Weiguang Biological Products Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Weiguang Biological Products Co Net Income From Continuing Operations Chart

Shenzhen Weiguang Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

171.15

189.59

204.99

121.21

217.55

Shenzhen Weiguang Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															45.63	55.26	50.46	66.20	46.79

Shenzhen Weiguang Biological Products Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥219 Mil.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107

Website

http://www.szwg.com

Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Executives

Guo Cai Ping

Executives

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines